Diana Hausman, Chief Medical Officer at Oncothyreon Inc. (ONTY), bought 5,747 shares at $4.65 ($27K) on 2015-06-01, disclosed to the SEC on 2015-06-03.
Open-market purchase of $27k ONTY by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ZYME | SELL | 2021-03-12 | $37K | — | Filing → |
| ZYME | SELL | 2020-12-04 | $665K | — | Filing → |
| ZYME | SELL | 2020-12-03 | $2.1M | — | Filing → |